Table of Contents
List of Tables 4
List of Figures 5
Report Guidance 6
GlobalData Clinical Trials Report Coverage 7
Clinical Trials by Region 8
Clinical Trials and Average Enrollment by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
Top Five Countries Contributing to Clinical Trials in Europe 13
Top Countries Contributing to Clinical Trials in North America 14
Top Countries Contributing to Clinical Trials in Middle East and Africa 15
Top Countries Contributing to Clinical Trials in Central and South America 16
Clinical Trials by G7 Countries: Proportion of Primary Dysmenorrhea to Women’s Health Clinical Trials 17
Clinical Trials by Phase in G7 Countries 19
Clinical Trials in G7 Countries by Trial Status 20
Clinical Trials by E7 Countries: Proportion of Primary Dysmenorrhea to Women’s Health Clinical Trials 21
Clinical Trials by Phase in E7 Countries 23
Clinical Trials in E7 Countries by Trial Status 24
Clinical Trials by Phase 26
In Progress Trials by Phase 27
Clinical Trials by Trial Status 28
Clinical Trials by End Point Status 30
Subjects Recruited Over a Period of Time 31
Clinical Trials by Sponsor Type 33
Prominent Sponsors 34
Top Companies Participating in Primary Dysmenorrhea Therapeutics Clinical Trials 36
Prominent Drugs 38
Latest Clinical Trials News on Primary Dysmenorrhea 39
Sep 25, 2019: Aleve demonstrates more pain relief than Acetaminophen for Menstrual Cramps, study shows 39
Clinical Trial Profile Snapshots 40
Appendix 169
Abbreviations 169
Definitions 169
Research Methodology 170
Secondary Research 170
About GlobalData 171
Contact Us 171
Source 172
Primary Dysmenorrhea Therapeutics, Global, Clinical Trials by Region, 2019* 8
Primary Dysmenorrhea Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 10
Primary Dysmenorrhea Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 11
Primary Dysmenorrhea Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2019* 12
Primary Dysmenorrhea Therapeutics Clinical Trials, Europe, Top Five Countries, 2019* 13
Primary Dysmenorrhea Therapeutics Clinical Trials, North America, Top Countries, 2019* 14
Primary Dysmenorrhea Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2019* 15
Primary Dysmenorrhea Therapeutics Clinical Trials, Central and South America, Top Countries, 2019* 16
Proportion of Primary Dysmenorrhea to Women's Health Clinical Trials, G7 Countries (%), 2019* 18
Primary Dysmenorrhea Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 19
Primary Dysmenorrhea Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 20
Proportion of Primary Dysmenorrhea to Women's Health Clinical Trials, E7 Countries (%), 2019* 22
Primary Dysmenorrhea Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 23
Primary Dysmenorrhea Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 25
Primary Dysmenorrhea Therapeutics, Global, Clinical Trials by Phase, 2019* 26
Primary Dysmenorrhea Therapeutics, Global, Clinical Trials In Progress by Phase 2019* 27
Primary Dysmenorrhea Therapeutics, Global, Clinical Trials by Trial Status, 2019* 29
Primary Dysmenorrhea Therapeutics Clinical Trials, Global, by End Point Status, 2019* 30
Primary Dysmenorrhea Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 32
Primary Dysmenorrhea Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2019* 33
Primary Dysmenorrhea Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 35
Primary Dysmenorrhea Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 37
Primary Dysmenorrhea Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 38
List of Figures
Primary Dysmenorrhea Therapeutics, Global, Clinical Trials by Region (%), 2019* 8
Primary Dysmenorrhea Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 9
Primary Dysmenorrhea Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 11
Primary Dysmenorrhea Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2019* 12
Primary Dysmenorrhea Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2019* 13
Primary Dysmenorrhea Therapeutics Clinical Trials, North America, Top Countries (%), 2019* 14
Primary Dysmenorrhea Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2019* 15
Primary Dysmenorrhea Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2019* 16
Proportion of Primary Dysmenorrhea to Women's Health Clinical Trials, G7 Countries (%), 2019* 17
Primary Dysmenorrhea Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 19
Primary Dysmenorrhea Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 20
Proportion of Primary Dysmenorrhea to Women's Health Clinical Trials, E7 Countries (%), 2019* 21
Primary Dysmenorrhea Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 23
Primary Dysmenorrhea Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 24
Primary Dysmenorrhea Therapeutics, Global, Clinical Trials by Phase (%), 2019* 26
Primary Dysmenorrhea Therapeutics, Global, Clinical Trials In Progress by Phase, 2019* 27
Primary Dysmenorrhea Therapeutics, Global, Clinical Trials by Trial Status, 2019* 28
Primary Dysmenorrhea Therapeutics Clinical Trials, Global, by End Point Status, 2019* 30
Primary Dysmenorrhea Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 31
Primary Dysmenorrhea Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2019* 33
Primary Dysmenorrhea Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 34
Primary Dysmenorrhea Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 36
Primary Dysmenorrhea Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 38
GlobalData Methodology 170
【免責事項】
https://www.marketreport.jp/reports-disclaimer